 |
|
CLINICIAN'S CORNER
Oral Antihyperglycemic Therapy for Type 2 Diabetes
Clinical Applications
Eric S. Holmboe, MD
JAMA. 2002;287:373-376.
Oral agents are the mainstay of pharmacologic treatment for type 2 diabetes, and physicians now have a number of agents to choose from. However, more choices translate into more complex decision making. Many patients with diabetes have associated comorbidities, and most diabetic patients will require more than 1 agent to achieve good glycemic control. This article illustrates several of the pharmacologic approaches to type 2 diabetes through 4 situations that use principles of evidence-based medicine. The scenarios also highlight some of the difficulties in choosing the optimal pharmacologic treatment regimen for individual patients. Physicians should also recognize that type 2 diabetes is a multisystem disorder that requires multidisciplinary care, including education and ongoing counseling for effective patient self-management of the disease. Finally, patient preferences are a vital component of informed decision making for pharmacologic treatment of diabetes.
Author Affiliations: Department of Medicine, Yale University School of Medicine, New Haven, Conn, and Qualidigm (Connecticut Peer Review Organization), Middletown, Conn.
RELATED LETTER
Treatment Decisions for Type 2 Diabetes
Mayer B. Davidson and Eric S. Holmboe
JAMA. 2002;287(13):1646-1648.
EXTRACT
| FULL TEXT
RELATED ARTICLES
Oral Antihyperglycemic Therapy for Type 2 Diabetes: Scientific Review
Silvio E. Inzucchi
JAMA. 2002;287(3):360-372.
ABSTRACT
| FULL TEXT
Scientific Review and Clinical Applications
Wendy Levinson and Catherine D. DeAngelis
JAMA. 2002;287(3):379.
EXTRACT
| FULL TEXT
January 16, 2002
JAMA. 2002;287(3):387-388.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Beneath the surface: discovering the unvoiced concerns of older adults with Type 2 diabetes mellitus
Tjia et al.
Health Educ Res 2008;23:40-52.
ABSTRACT
| FULL TEXT
Pharmacy Costs and Glycemic Control in the Department of Veterans Affairs
Weinstock et al.
Diabetes Care 2004;27:B74-B81.
ABSTRACT
| FULL TEXT
Outpatient Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: Scientific Review
DeWitt and Hirsch
JAMA 2003;289:2254-2264.
ABSTRACT
| FULL TEXT
Using New Insulin Strategies in the Outpatient Treatment of Diabetes: Clinical Applications
DeWitt and Dugdale
JAMA 2003;289:2265-2269.
ABSTRACT
| FULL TEXT
Pharmacological Agents That Directly Modulate Insulin Secretion
Doyle and Egan
Pharmacol. Rev. 2003;55:105-131.
ABSTRACT
| FULL TEXT
Helping Patients Follow Prescribed Treatment: Clinical Applications
Haynes et al.
JAMA 2002;288:2880-2883.
ABSTRACT
| FULL TEXT
Treatment Decisions for Type 2 Diabetes
Davidson and Holmboe
JAMA 2002;287:1646-1648.
FULL TEXT
Scientific Review and Clinical Applications
Levinson and DeAngelis
JAMA 2002;287:379-379.
FULL TEXT
|
